Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats

References

• Durazzo A, D’addezio L, Camilli E, et al. From plant compounds to botanicals and back: a current snapshot. Molecules. 2018;23(8):e1844. doi:10.3390/molecules23081844
   PubMed Web of Science ®Google Scholar
• Salehi B, Ata A, Anil Kumar N, et al. Antidiabetic potential of medicinal plants and their active components. Biomolecules. 2019;9(10):e551. doi:10.3390/biom9100551
   PubMed Web of Science ®Google Scholar
• Payab M, Hasani-Ranjbar S, Shahbal N, et al. Effect of the herbal medicines in obesity and metabolic syndrome: a systematic review and meta‐analysis of clinical trials. Phytother Res. 2020;34(3):526–545. doi:10.1002/ptr.6547
   PubMed Web of Science ®Google Scholar
• Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577–1585. doi:10.1007/s00125-017-4342-z
   PubMed Web of Science ®Google Scholar
• Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15(10):569–589. doi:10.1038/s41574-019-0242-2
   PubMed Web of Science ®Google Scholar
• Cahn A, Cefalu WT. Clinical considerations for use of initial combination therapy in type 2 Diabetes. Diabetes Care. 2016;39(Suppl 2):137–145. doi:10.2337/dcS15-3007
   PubMed Web of Science ®Google Scholar
• Akhter MS, Uppal P. Toxicity of metformin and hypoglycemic therapies. Adv Chronic Kidney D. 2020;27(1):18–30. doi:10.1053/j.ackd.2019.08.004
   PubMedGoogle Scholar
• Prabhakar PK, Kumar A, Doble M. Combination therapy: a new strategy to manage diabetes and its complications. Phytomedicine. 2014;21(2):123–130. doi:10.1016/j.phymed.2013.08.020
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, Chiu HF, Wang CK. Popular functional foods and herbs for the management of type-2-diabetes mellitus: a comprehensive review with special reference to clinical trials and its proposed mechanism. J Funct Foods. 2019;57:425–438. doi:10.1016/j.jff.2019.04.039
   Google Scholar
• Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118–126. doi:10.4103/0973-7847.70902
   PubMedGoogle Scholar
• Yeh WJ, Hsia SM, Lee WH, Wu CH. Polyphenols with antiglycation activity and mechanisms of action: a review of recent findings. J Food Drug Anal. 2017;25(1):84–92. doi:10.1016/j.jfda.2016.10.017
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93(7):2559–2565. doi:10.1210/jc.2007-2404
   PubMed Web of Science ®Google Scholar
• Grabowska M, Wawrzyniak D, Rolle K, et al. Let food be your medicine: nutraceutical properties of lycopene. Food Funct. 2019;10(6):3090–3102. doi:10.1039/C9FO00580C
   PubMedGoogle Scholar
• Przybylska S. Lycopene–a bioactive carotenoid offering multiple health benefits: a review. Int J Food Sci Tech. 2020;55(1):11–32. doi:10.1111/ijfs.14260
   Web of Science ®Google Scholar
• Banihani SA. Tomato (Solanum lycopersicum L.) and type 2 diabetes. Int J Food Prop. 2018;21(1):99–105. doi:10.1080/10942912.2018.1439959
   Web of Science ®Google Scholar
• Pierine DT, Navarro ME, Minatel IO, et al. Lycopene supplementation reduces TNF-α via RAGE in the kidney of obese rats. Nutr Diabetes. 2014;4:e142. doi:10.1038/nutd.2014.39
   PubMed Web of Science ®Google Scholar
• Tabrez S, Al‐Shali KZ, Ahmad S. Lycopene powers the inhibition of glycation‐induced diabetic nephropathy: a novel approach to halt the AGE‐RAGE axis menace. Biofactors. 2015;41(5):372–381. doi:10.1002/biof.1238
   PubMedGoogle Scholar
• Assis RP, Arcaro CA, Gutierres VO, et al. Combined effects of curcumin and lycopene or bixin in yoghurt on inhibition of LDL oxidation and increases in HDL and paraoxonase levels in streptozotocin-diabetic rats. Int J Mol Sci. 2017;18:e332. doi:10.3390/ijms18040332
   PubMed Web of Science ®Google Scholar
• Roxo DF, Arcaro CA, Gutierres VO, et al. Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats. Diabetol Metab Syndr. 2019;11(1):33. doi:10.1186/s13098-019-0431-0
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and assay applicable to acrylamide gels. Anal Biochem. 1971;44(1):276–287. doi:10.1016/0003-2697(71)90370-8
   PubMed Web of Science ®Google Scholar
• Beers RF Jr, Sizer IW. A spectrophotometric method of measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;195(1):133–140.
   PubMed Web of Science ®Google Scholar
• Rush JWE, Sandiford SD. Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity. Clin Biochem. 2003;36(5):345–351. doi:10.1016/S0009-9120(03)00039-0
   PubMed Web of Science ®Google Scholar
• Carlberg I, Mannervik B. Glutathione reductase. Method Enzymol. 1985;113:484–490. doi:10.1016/S0076-6879(85)13062-4
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25(1):192–205. doi:10.1016/0003-2697(68)90092-4
   PubMed Web of Science ®Google Scholar
• Kohn HI, Liversedge M. On a new aerobic metabolite whose production by brain is inhibited by apomorphine, emetine, ergotamine, epinephrine, and menadione. J Pharmacol Exp Ther. 1944;82(3):292–300.
   Google Scholar
• Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1944;233:346–357. doi:10.1016/s0076-6879(94)33040-9
   Google Scholar
• Costa MC, Lima TFO, Arcaro CA, et al. Trigonelline and curcumin alone, but not in combination, counteract oxidative stress and inflammation and increase glycation product detoxification in the liver and kidney of mice with high-fat diet-induced obesity. J Nutr Biochem. 2020;76:108303. doi:10.1016/j.jnutbio.2019.108303
   PubMed Web of Science ®Google Scholar
• Meier JJ, Baller B, Menge BA, Gallwitz B, Schmidt WE, Nauck MA. Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa? Diabetes Obes Metab. 2009;11(3):213–222. doi:10.1111/j.1463-1326.2008.00922.x
   PubMedGoogle Scholar
• Gutierres VO, Assis RP, Arcaro CA, et al. Curcumin improves the effect of a reduced insulin dose on glycemic control and oxidative stress in streptozotocin‐diabetic rats. Phytother Res. 2019;33(4):976–988. doi:10.1002/ptr.6291
   PubMedGoogle Scholar
• Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr. 2010;103(12):1778–1783. doi:10.1017/S0007114509993801
   PubMed Web of Science ®Google Scholar
• Balakumar M, Prabhu D, Sathishkumar C, et al. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur J Nutr. 2018;57(1):279–295. doi:10.1007/s00394-016-1317-7
   PubMed Web of Science ®Google Scholar
• Gutierres VO, Pinheiro CM, Assis RP, Vendramini RC, Pepato MT, Brunetti IL. Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes. Br J Nutr. 2012;108(3):440–448. doi:10.1017/S0007114511005769
   PubMedGoogle Scholar
• Zeng Z, He W, Jia Z, Hao S. Lycopene improves insulin sensitivity through inhibition of STAT3/Srebp-1c-mediated lipid accumulation and inflammation in mice fed a high-fat diet. Exp Clin Endocrinol Diabetes. 2017;125(9):610–617. doi:10.1055/s-0043-101919
   PubMedGoogle Scholar
• Zidani S, Benakmoum A, Ammouche A, Benali Y, Bouhadef A, Abbeddou S. Effect of dry tomato peel supplementation on glucose tolerance, insulin resistance, and hepatic markers in mice fed high-saturated-fat/high-cholesterol diets. J Nutr Biochem. 2017;40:64–171. doi:0.1016/j.jnutbio.2016.11.001
   Google Scholar
• Zhu R, Chen B, Bai Y, et al. Lycopene in protection against obesity and diabetes: a mechanistic review. Pharmacol Res. 2020;159:104966. doi:10.1016/j.phrs.2020.104966
   PubMed Web of Science ®Google Scholar
• Ozmen O, Topsakal S, Haligur M, Aydogan A, Dincoglu D. Effects of caffeine and lycopene in experimentally induced diabetes mellitus. Pancreas. 2016;45(4):579–583. doi:10.1097/MPA.0000000000000489
   PubMedGoogle Scholar
• Li H, Chen A, Zhao L, et al. Effect of tomato consumption on fasting blood glucose and lipid profiles: a systematic review and meta‐analysis of randomized controlled trials. Phytother Res. 2020;34(8):1956–1965. doi:10.1002/ptr.6660
   PubMedGoogle Scholar
• Prasad AK, Mishra PC. Modeling the mechanism of action of lycopene as a hydroxyl radical scavenger. J Mol Model. 2014;20(5):2233. doi:10.1007/s00894-014-2233-5
   PubMedGoogle Scholar
• Pennathur S, Maitra D, Byun J, et al. Potent antioxidative activity of lycopene: a potential role in scavenging hypochlorous acid. Free Radic Biol Med. 2010;49(2):205–213. doi:10.1016/j.freeradbiomed.2010.04.003
   PubMedGoogle Scholar
• Bondeva T, Wolf G. Reactive oxygen species in diabetic nephropathy: friend or foe? Nephrol Dial Transpl. 2014;29(11):1998–2003. doi:10.1093/ndt/gfu037
   PubMed Web of Science ®Google Scholar
• Ghoshal K, Das S, Aich K, Goswami S, Chowdhury S, Bhattacharyya M. A novel sensor to estimate the prevalence of hypochlorous (HOCl) toxicity in individuals with type 2 diabetes and dyslipidemia. Clin Chim Acta. 2016;458:144–153. doi:10.1016/j.cca.2016.05.006
   PubMedGoogle Scholar
• Ali MM, Agha FG. Amelioration of streptozotocin‐induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Inv. 2009;69(3):371–379. doi:10.1080/00365510802658473
   PubMed Web of Science ®Google Scholar
• Van Stee MF, De Graaf AA, Groen AK. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. Cardiovasc Diabetol. 2018;17(1):94. doi:10.1186/s12933-018-0738-4
   PubMed Web of Science ®Google Scholar
• Corremans R, Vervaet BA, D’haese PC, Neven E, Verhulst A. Metformin: a candidate drug for renal diseases. Int J Mol Sci. 2018;20(1):42. doi:10.3390/ijms20010042
   PubMed Web of Science ®Google Scholar
• Karise I, Ornel Las F, Barbosa-Da-Silva S, et al. Liver and Metformin: lessons of a fructose diet in mice. Biochim Open. 2017;4:19–30. doi:10.1016/j.biopen.2017.01.002
   PubMedGoogle Scholar
• Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem-Biol Interact. 2011;192(3):233–242. doi:10.1016/j.cbi.2011.03.014
   PubMed Web of Science ®Google Scholar
• Levy D, Reichert CO, Bydlowski SP. Paraoxonases activities and polymorphisms in elderly and old-age diseases: an overview. Antioxidants. 2019;8(5):118. doi:10.3390/antiox8050118
   Google Scholar
• Mastorikou M, Mackness B, Liu Y, Mackness M. Glycation of paraoxonase‐1 inhibits its activity and impairs the ability of high‐density lipoprotein to metabolize membrane lipid hydroperoxides. Diabetic Med. 2008;25(9):1049–1055. doi:10.1111/j.1464-5491.2008.02546.x
   PubMed Web of Science ®Google Scholar
• Meaney E, Sierra‐Vargas P, Meaney A, et al. Does metformin increase paraoxonase activity in patients with the metabolic syndrome? Additional data from the MEFISTO study. Clin Transl Sci. 2012;5(3):265–268. doi:10.1111/j.1752-8062.2012.00391.x
   PubMedGoogle Scholar
• Kinsky OR, Hargraves TL, Anumol T, et al. Metformin scavenges methylglyoxal to form a novel imidazolinone metabolite in humans. Chem Res. 2016;29(2):227–234. doi:10.1021/acs.chemrestox.5b00497
   Google Scholar
• Ceriello A, Ihnat MA, Thorpe JE. The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009;94(2):410–415. doi:10.1210/jc.2008-1824
   PubMed Web of Science ®Google Scholar
• Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A. The “metabolic memory” theory and the early treatment of hyperglycemia in prevention of diabetic complications. Nutrients. 2017;9(5):437. doi:10.3390/nu9050437
   PubMed Web of Science ®Google Scholar
• Ceriello A. The emerging challenge in diabetes: the “metabolic memory”. Vasc Pharmacol. 2012;57(5–6):133–138. doi:10.1016/j.vph.2012.05.005
   PubMedGoogle Scholar
• Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes. 2005;54(1):1–7. doi:10.2337/diabetes.54.1.1
   PubMed Web of Science ®Google Scholar
• Zeng YC, Peng LS, Zou L, et al. Protective effect and mechanism of lycopene on endothelial progenitor cells (EPCs) from type 2 diabetes mellitus rats. Biomed Pharmacother. 2017b;92:86–94. doi:10.1016/j.biopha.2017.05.018
   PubMed Web of Science ®Google Scholar
• McEneny J, Wade L, Young IS, et al. Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J Nutr Biochem. 2013;24(1):163–168. doi:10.1016/j.jnutbio.2012.03.015
   PubMedGoogle Scholar
• Gunawardena HP, Silva R, Sivakanesan R, Ranasinghe P, Katulanda P. Poor glycaemic control is associated with increased lipid peroxidation and glutathione peroxidase activity in type 2 diabetes patients. Oxid Med Cell Longev. 2019;2019:9471697. doi:10.1155/2019/9471697
   PubMed Web of Science ®Google Scholar
• De Haan JB, Stefanovic N, Nikolic-Paterson D, et al. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol. 2005;289(3):544–551. doi:10.1152/ajprenal.00088.2005
   Google Scholar